Digital Breast Tomosynthesis Guided Tomographic Optical Breast Imaging (TOBI)
NCT ID: NCT02033486
Last Updated: 2019-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
375 participants
INTERVENTIONAL
2014-03-31
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy
NCT03822312
TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer
NCT00783757
The Added Value of DBT Over Mammography in Local Tumor Staging in Patients With BIRADS 4 or 5 Lesions
NCT06854887
Early Detection of Breast Cancer Using Tomosynthesis Imaging
NCT00637598
Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
NCT01669148
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TOBI + DBT
TOBI + DBT of women presenting for breast imaging.
TOBI + DBT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TOBI + DBT
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for a clinically indicated diagnostic mammogram or percutaneous biopsy.
* presenting for breast cancer treatment
Exclusion Criteria
* Is pregnant or thinks she may become pregnant.
* Open wounds on breast
* Breast implants
* Any condition that impairs the ability to give informed consent
30 Years
80 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mansi A Saksena
Assistant Professor at Massachusetts General Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefan A Carp, PhD
Role: STUDY_DIRECTOR
Massachusetts General Hospital
Mansi Saksena, MBBS
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stefan Carp
Charlestown, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.